Financial statements Extrapharm
Balance sheet data of EXTRAPHARM
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 51 326,38 | 32 861,16 | 21 389,65 | 6 227,51 | 40 215,92 | 64 788,25 |
A. Fixed assets | 2 916,06 | 2 436,69 | 0,00 | 2 000,00 | 3 000,00 | 3 000,00 |
B. Current assets | 48 410,32 | 30 424,47 | 21 389,65 | 4 227,51 | 37 215,92 | 61 788,25 |
C. Share capital contributions (basic funds) | - | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - | - |
Total liabilities | 51 326,38 | 32 861,16 | 21 389,65 | 6 227,51 | 40 215,92 | 64 788,25 |
A. Equity | 41 262,38 | 22 079,16 | 9 768,82 | -8 595,28 | 33 261,36 | 64 173,25 |
B. Liabilities and provisions for liabilities | 10 064,00 | 10 782,00 | 11 620,83 | 14 822,79 | 6 954,56 | 615,00 |
I. Long-term liabilities | - | - | - | - | - | - |
II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.